Publications by authors named "Max Sander"

Claim this Profile
I
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors.
Deli Song, Xudong Jia, Xincheng Liu, Linyi Hu, Kaiying Lin, Max Sander

Signal Transduct Target Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.
Jiayi Zeng, Xiangxue Li, Max Sander, Haipeng Zhang, Guangmei Yan

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC.
Jiayu Zhang, Ying Liu, Jingyi Tan, Yanming Zhang, Chun-Wa Wong, Max Sander

Oncogene· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1.
Jing Cai, Kaiying Lin, Wei Cai, Yuan Lin, Xincheng Liu, Max Sander

Mol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc-finger antiviral protein acts as a tumor suppressor in colorectal cancer.
Jing Cai, Wenfeng Liu, Chun Wa Wong, Wenbo Zhu, Yuan Lin, Max Sander

Oncogene· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short stature explained by dimerization of human growth hormone induced by a p.C53S point mutation.
Max Sander, Zida Wu, Christian J Strasburger

J Biol Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis